Summit Partners Public Asset Management, LLC Collegium Pharmaceutical, Inc Transaction History

Summit Partners Public Asset Management, LLC

  • $4.13 Billion
  • Q4 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2018

Nov 14, 2018
SELL
$14.16 - $24.3 $4.14 Million - $7.1 Million
-292,098 Closed
0 $0
Q2 2018

Aug 14, 2018
SELL
$21.79 - $28.29 $3.3 Million - $4.29 Million
-151,528 Reduced 34.16%
292,098 $6.97 Million
Q1 2018

May 15, 2018
SELL
$18.15 - $29.21 $297,188 - $478,284
-16,374 Reduced 3.56%
443,626 $11.3 Million
Q4 2017

Feb 14, 2018
BUY
$9.3 - $19.14 $4.28 Million - $8.8 Million
460,000
460,000 $8.49 Million

Others Institutions Holding COLL

# of Institutions
247
Shares Held
37.3M
Call Options Held
59.3K
Put Options Held
9.5K
View Full List

About COLLEGIUM PHARMACEUTICAL, INC

COLL Quotes by TradingView
  • Ticker COLL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 34,126,200
  • Market Cap $1.01B
  • Description
  • Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ...
More about COLL
Track This Portfolio

Track Summit Partners Public Asset Management, LLC Portfolio

Follow Summit Partners Public Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Summit Partners Public Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Summit Partners Public Asset Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email